190 related articles for article (PubMed ID: 20874694)
1. Homocysteine in neurological disease: a marker or a cause?
Khanna S; Kapoor P; Pillai KK; Vohora D
CNS Neurol Disord Drug Targets; 2011 May; 10(3):361-9. PubMed ID: 20874694
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia in renal diseases.
Ferechide D; Radulescu D
J Med Life; 2009; 2(1):53-9. PubMed ID: 20108491
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia and cardiovascular disease in animal model.
Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine, vitamin determinants and neurological diseases.
Ientile R; Curro' M; Ferlazzo N; Condello S; Caccamo D; Pisani F
Front Biosci (Schol Ed); 2010 Jan; 2(1):359-72. PubMed ID: 20036953
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine Modification in Protein Structure/Function and Human Disease.
Jakubowski H
Physiol Rev; 2019 Jan; 99(1):555-604. PubMed ID: 30427275
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and cardiovascular disease in renal disease.
Austen SK; Coombes JS; Fassett RG
Nephrology (Carlton); 2003 Dec; 8(6):285-95. PubMed ID: 15012699
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of hyperhomocysteinemia].
Veyrat-Durebex C; Blasco H; Crinier J; Vayne C; Emond P; Labarthe F; Andres CR; Maillot F
Ann Biol Clin (Paris); 2013; 71(5):517-25. PubMed ID: 24113437
[TBL] [Abstract][Full Text] [Related]
9. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine and Parkinson's disease: a dangerous liaison?
Martignoni E; Tassorelli C; Nappi G; Zangaglia R; Pacchetti C; Blandini F
J Neurol Sci; 2007 Jun; 257(1-2):31-7. PubMed ID: 17336337
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and risk for atherothrombotic events.
Puddu P
Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia as a risk factor for the neuronal system disorders.
Petras M; Tatarkova Z; Kovalska M; Mokra D; Dobrota D; Lehotsky J; Drgova A
J Physiol Pharmacol; 2014 Feb; 65(1):15-23. PubMed ID: 24622826
[TBL] [Abstract][Full Text] [Related]
13. [Homocysteine and neuropsychiatric disorders].
Sachdev P
Braz J Psychiatry; 2004 Mar; 26(1):50-6. PubMed ID: 15057841
[TBL] [Abstract][Full Text] [Related]
14. The association of homocysteine and coronary artery disease.
Gauthier GM; Keevil JG; McBride PE
Clin Cardiol; 2003 Dec; 26(12):563-8. PubMed ID: 14677809
[TBL] [Abstract][Full Text] [Related]
15. [Homocysteine metabolism disorders as a potential predictor of preeclamsia].
Kajdy A; Niemiec T
Ginekol Pol; 2008 Nov; 79(11):775-9. PubMed ID: 19140501
[TBL] [Abstract][Full Text] [Related]
16. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
Herrmann W; Lorenzl S; Obeid R
Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine imbalance: a pathological metabolic marker.
Schalinske KL; Smazal AL
Adv Nutr; 2012 Nov; 3(6):755-62. PubMed ID: 23153729
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis.
García-Tevijano ER; Berasain C; Rodríguez JA; Corrales FJ; Arias R; Martín-Duce A; Caballería J; Mato JM; Avila MA
Hypertension; 2001 Nov; 38(5):1217-21. PubMed ID: 11711526
[TBL] [Abstract][Full Text] [Related]
19. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
20. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.
Riksen NP; Rongen GA; Blom HJ; Russel FG; Boers GH; Smits P
Cardiovasc Res; 2003 Aug; 59(2):271-6. PubMed ID: 12909310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
